Amgen Inc. (AMGN) Q4 2025 Earnings Call Transcript
Good afternoon, everyone, and welcome to our fourth quarter 2025 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Jay Bradner, Murdo Gordon ...
Merck is said to halt acquisition talks with cancer drug developer Revolution
The pharmaceutical giant had been in talks to buy the cancer drug developer in a transaction that could have valued ...
Merck no longer in talks to buy Revolution Medicines, WSJ reports
Jan 25 (Reuters) - Merck is no longer in discussions to buy cancer drug developer Revolution Medicines, the Wall Street ...
Merck No Longer in Talks to Buy Revolution Medicines
The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.
Merck Ends Talks to Buy Revolution Medicines, WSJ Reports
Merck & Co. is no longer in talks to acquire biotech firm Revolution Medicines Inc. after the two companies couldn’t agree on ...
Benzinga.com
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight
The deal is yet to be finalized and any potential tie-ups are weeks away, according to a report by the Financial Times citing sources familiar with the matter. This comes amid a looming patent cliff ...
Reuters
Merck in talks to buy biotech Revolution in up to $32 billion deal, FT reports
Jan 8 (Reuters) - Merck (MRK.N), opens new tab is in talks to buy cancer drug developer Revolution Medicines (RVMD.O), opens new tab in a $28 billion to $32 billion deal, the Financial Times reported ...
BioPharma Dive
Halozyme buys a biotech startup; Cytokinetics launches heart drug
Halozyme is paying as much as $400 million for a drug delivery specialist that could boost its growth prospects, one analyst ...
Wall Street Journal
Merck in Talks to Buy Revolution Medicines for Around $30 Billion
Merck MRK1.35%increase; green up pointing triangle is in talks to acquire Revolution Medicines RVMD 0.89%increase; green up pointing triangle in a deal that could value it at around $30 billion, ...
FiercePharma
CEPI bankrolls $30M Ebola vaccine collaboration with Merck, SK Bioscience and others
With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. is bringing together several global vaccine makers to develop an updated Ebola vaccine to ...
KBIA
Heart disease deaths declined. And here's how to reduce your risk of the #1 killer
About every 34 seconds, someone, somewhere in the United States dies from heart disease — which remains the leading cause of death for both men and women, according to the American Heart Association.
The New York Times
7 Things All Women Should Know About Their Heart Health
Women’s cardiovascular health has long been overlooked and understudied. Here are some things to keep in mind. By Maggie Astor Heart disease kills more women than all cancers combined. But many women ...